Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
102.70
+0.20 (0.20%)
At close: Mar 4, 2026
-18.75%
Market Cap 23.72B
Revenue (ttm) 11.58B
Net Income (ttm) 570.05M
Shares Out 231.00M
EPS (ttm) 2.47
PE Ratio 41.62
Forward PE n/a
Dividend 2.10 (2.05%)
Ex-Dividend Date Nov 17, 2025
Volume 162,112
Average Volume 364,729
Open n/a
Previous Close 102.50
Day's Range 100.50 - 104.60
52-Week Range 92.40 - 147.50
Beta -0.63
RSI 40.48
Earnings Date Apr 29, 2026

About Beacon Pharmaceuticals

Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech products, and genetic engineering products in Bangladesh and internationally. The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories that include oncology, hematology, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointesti... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 4,162
Stock Exchange Dhaka Stock Exchange
Ticker Symbol BEACONPHAR
Full Company Profile

Financial Performance

In fiscal year 2024, Beacon Pharmaceuticals's revenue was 10.70 billion, an increase of 25.76% compared to the previous year's 8.51 billion. Earnings were 521.01 million, an increase of 2.19%.

Financial Statements

News

There is no news available yet.